+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Implantable Infusion Pumps Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5185310
  • Report
  • November 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CareFusion Corporation
  • Flowonix Medical, Inc.
  • ICU Medical, Inc.
  • Medtronic
  • Neuropace
  • MORE
Implantable Infusion Pumps Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global implantable infusion pumps market.

This report focuses on implantable infusion pumps market which is experiencing strong growth. The report gives a guide to the implantable infusion pumps market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the implantable infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Implantable Infusion Pumps market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider implantable infusion pumps market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The implantable infusion pumps market section of the report gives context. It compares the implantable infusion pumps market with other segments of the implantable infusion pumps market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, implantable infusion pumps indicators comparison.
Scope

Markets Covered:
1) By Type: Patient-Controlled Analgesia (PCA) Pumps; Enteral Pumps; Insulin Pumps; Elastomeric Pumps; Syringe Pumps; Others
2) By Applications: Oncology; Pediatrics/Neonatology; Gastroenterology; Hematology; Diabetes; Others

Companies Mentioned: Medtronic; Boston Scientific Corporation; Nevro Corporation; Cyberonics; Baxter

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CareFusion Corporation
  • Flowonix Medical, Inc.
  • ICU Medical, Inc.
  • Medtronic
  • Neuropace
  • MORE
1. Executive Summary

2. Implantable Infusion Pumps Market Characteristics

3. Implantable Infusion Pumps Market Size And Growth
3.1. Global Implantable Infusion Pumps Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Implantable Infusion Pumps Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Implantable Infusion Pumps Market Segmentation
4.1. Global Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Patient-Controlled Analgesia (PCA) Pumps
  • Enteral Pumps
  • Insulin Pumps
  • Elastomeric Pumps
  • Syringe Pumps
  • Others
4.2. Global Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes
  • Others
5. Implantable Infusion Pumps Market Regional And Country Analysis
5.1. Global Implantable Infusion Pumps Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Implantable Infusion Pumps Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Implantable Infusion Pumps Market
6.1. Asia-Pacific Implantable Infusion Pumps Market Overview
6.2. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Implantable Infusion Pumps Market
7.1. China Implantable Infusion Pumps Market Overview
7.2. China Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Implantable Infusion Pumps Market
8.1. India Implantable Infusion Pumps Market Overview
8.2. India Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Implantable Infusion Pumps Market
9.1. Japan Implantable Infusion Pumps Market Overview
9.2. Japan Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Implantable Infusion Pumps Market
10.1. Australia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Implantable Infusion Pumps Market
11.1. Indonesia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Implantable Infusion Pumps Market
12.1. South Korea Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Implantable Infusion Pumps Market
13.1. Western Europe Implantable Infusion Pumps Market Overview
13.2. Western Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Implantable Infusion Pumps Market
14.1. UK Implantable Infusion Pumps Market Overview
14.2. UK Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Implantable Infusion Pumps Market
15.1. Germany Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Implantable Infusion Pumps Market
16.3. France Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Implantable Infusion Pumps Market
17.1. Eastern Europe Implantable Infusion Pumps Market Overview
17.2. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Implantable Infusion Pumps Market
18.1. Russia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Implantable Infusion Pumps Market
19.1. North America Implantable Infusion Pumps Market Overview
19.2. North America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Implantable Infusion Pumps Market
20.1. USA Implantable Infusion Pumps Market Overview
20.2. USA Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Implantable Infusion Pumps Market
21.1. South America Implantable Infusion Pumps Market Overview
21.2. South America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Implantable Infusion Pumps Market
22.1. Brazil Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Implantable Infusion Pumps Market
23.1. Middle East Implantable Infusion Pumps Market Overview
23.2. Middle East Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Implantable Infusion Pumps Market
24.1. Africa Implantable Infusion Pumps Market Overview
24.2. Africa Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Implantable Infusion Pumps Market Competitive Landscape And Company Profiles
25.1. Implantable Infusion Pumps Market Competitive Landscape
25.2. Implantable Infusion Pumps Market Company Profiles
25.2.1. Medtronic
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Boston Scientific Corporation
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Nevro Corporation
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Cyberonics
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Baxter
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Implantable Infusion Pumps Market

27. Implantable Infusion Pumps Market Trends And Strategies

28. Implantable Infusion Pumps Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CareFusion Corporation
  • Flowonix Medical, Inc.
  • ICU Medical, Inc.
  • Medtronic
  • Neuropace
  • MORE
Major players in the implantable infusion pumps market are Medtronic, Boston Scientific Corporation, Nevro Corporation, Cyberonics, Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, Terumo Corporation and Neuropace.

The global implantable infusion pumps market is expected to grow from $13.32 billion in 2019 to $16.22 billion in 2020 at a compound annual growth rate (CAGR) of 21.75%. The growth is mainly due to the COVID-19 outbreak that has increased the demand for intravenous infusion pumps to treat the affected patients. The market is then expected to stabilize and reach $16.98 billion in 2023 from 2021 at a CAGR of 1.55%.

The implantable infusion pumps market consists of sales of implantable infusion pumps and related services by entities (organizations, sole traders and partnerships) that manufacture implantable infusion pumps. An implantable infusion pump is a small device that is put beneath the skin during the operation. The pump delivers the liquid pain medication to a different part of the body through a long, flexible tube called the catheter.

North America was the largest region in the implantable infusion pumps market in 2019.

The implantable infusion pumps market by type into patient-controlled analgesia (PCA) pumps; enteral pumps; insulin pumps; elastomeric pumps; syringe pumps; others and by applications into oncology; pediatrics/neonatology; gastroenterology; hematology; diabetes; others.

In September 2019, Baxter International Inc., a global medical products company, acquired Cheetah Medical for $190 million. This deal is expected to expand Baxter's product portfolio and strengthen the company's clinical outcomes with patient monitoring technology. Cheetah Medical is a US-based device company offering non-invasive cardiac output and hemodynamic monitoring devices including infusion pumps.

The safety concern regarding implantable infusion pumps is a key factor hampering the growth of the implantable infusion pumps market. The magnetic resonance (MR) system can be useful in the diagnosis of a wide range of conditions and diseases, but the MRI setting poses a risk factor for patients with implantable infusion pumps. An MRI examination can influence the programming or functionality of an infusion pump, even if specific requirements have been met. In 2018, the US food and drug administration received evidence of significant adverse effects including harm to the patient and death associated with the use of implantable infusion pumps in the MR field. Therefore, the safety concerns regarding implantable infusion pumps is expected to limit the growth of the implantable infusion pumps market.

Companies in the implantable infusion pump market are increasingly focusing on developing smart infusion pumps. The use of wireless technology in the health monitoring devices is increasing, which enhances the ease of usage, connectivity and data analysis. The integration of wireless technology allows the transfer of data from the device to a smartphone or a wireless device through Bluetooth or cellular connection for data processing and then to display the results, which can be used for further study and to check the health condition of the individual. Software platforms are being developed that allow patient monitoring and reduce human error. In June 2019, Ivenix, a US-based medical device company, received clearance for a new smart infusion pump, which reduces human and software error with more streamlined technology.

The increased prevalence of people with chronic pain, cancer and diabetes is expected to drive the demand for implantable infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, as the aging population and shifts in social behavior lead to a gradual increase in these diseases. In diseases such as chronic arachnoiditis, which is a condition where one of the membranes surrounding the spinal cord swells, implantable infusion pumps deliver lower dosages of drugs and tend to provide more efficient pain relief. The prevalence of chronic diseases is expected to increase by 57% by 2020, according to the World Health Organization. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the implantable infusion pumps market.
Note: Product cover images may vary from those shown
  • Medtronic
  • Boston Scientific Corporation
  • Nevro Corporation
  • Cyberonics
  • Baxter
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical
  • Terumo Corporation
  • Neuropace
  • Johnson Johnson
  • Greatbatch Medical
  • St. Jude Medical
  • Neuropace
  • CareFusion Corporation
  • Primetech Corporation
  • Flowonix Medical, Inc.
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Micrel Medical
  • Insulet Corporation
  • ICU Medical, Inc.
  • Becton Dickinson (BD)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll